---
schema_version: "secwatch.filing_event.v1"
accession: "0001285550-25-000010"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2025-08-12T23:59:59+00:00"
generated_at: "2026-05-17T14:18:49.559037+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro Q2 revenue record $9.2M (+17% YoY); secures up to $105M note financing

## Summary
- Record Q2 revenue $9.2M, up 17% YoY; neurosurgery segment revenue up 33% to $3.4M.
- Operating expenses $11.2M (+16% YoY); gross margin 60% vs 63% on higher inventory reserves.
- Entered $105M note financing with Oberland Capital; $30M funded at closing plus $3.5M stock purchase.
- Cash and equivalents $41.5M at June 30, compared to $20.1M at year-end 2024.
- Full-year 2025 revenue outlook reaffirmed at $36.0M-$41.0M.

## SEC filing metadata
- accession: 0001285550-25-000010
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2025-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000128555025000010/0001285550-25-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000128555025000010/clpt-20250812.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001285550-25-000010
- JSON: https://secwatch.observer/filing/0001285550-25-000010.json
- Plain text: https://secwatch.observer/filing/0001285550-25-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.